ANTHRACYCLINE-ANTIBODY CONJUGATES Russian patent published in 2009 - IPC A61K39/395 A61K47/48 A61P35/00 

Abstract RU 2349343 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention concerns medicine, particularly immunotherapy. Anthracycline-antibody conjugate linked by linker containing twice substituted cyclohexane ring is claimed. Antibody included in conjugate is linked to CD74 antigene highly expressed in B cell lymphomas, melanomas and other tumours. Conjugate is internalised by target cells and expressed again on cell surface. Invention also claims method of obtaining indicated conjugate by anthracycline medium conjugation with linker and further with thiene-restored monoclonal antibody. Conjugate can be administered to patients when immunotherapy is required.

EFFECT: efficient method of obtaining anthracycline medicine obtainment.

11 cl, 8 ex, 5 dwg

Similar patents RU2349343C2

Title Year Author Number
THERAPY OF METASTATIC UROTHELIAL CANCER USING ANTIBODY-DRUG CONJUGATE SATSITUZUMAB GOVITECAN (IMMU-132) 2017
  • Govindan Serengulam V.
  • Goldenberg David M.
RU2757395C2
IMMUNOTHERAPY OF MALIGNANT DISEASES OF B-CELLS AND AUTOIMMUNE DISEASES WITH APPLICATION OF CONJUGATE AND NONCONJUGATE ANTIBODIES, COMBINATIONS OF ANTIBODIES AND CONJOINT PROTEINS 2003
  • Goldenberg Dehvid M.
  • Khansen Khans
RU2335297C2
TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER CHARACTERIZED BY Trop-2 EXPRESSION USING SATSITUZUMAB GOVITECAN AND Rad51 INHIBITOR 2018
  • Cardillo Thomas M.
  • Goldenberg David M.
RU2758234C2
EFFICACY OF CONJUGATES OF ANTI-TROP-2 ANTIBODY WITH DRUG SN-38 FOR THERAPY OF RECURRENT/REFRACTORY TO INHIBITORS OF TUMOR CONTROL POINT 2017
  • Govindan Serengulam V.
  • Goldenberg David M.
RU2725292C2
HUMAN ANTIBODIES AND CONJUGATES OF ANTIBODY-PREPARATION AGAINST CD74 2012
  • Verplugen Sandra
  • Overdejk Mareje
  • Dejkkhejzen Rimke Van
  • Bleker Villem Karel
  • Berkel Patrik Van
  • Parren Paul
  • Lisbyu Sten
RU2636029C2
ANTIBODY-DRUG CONJUGATE LOADED WITH BINARY TOXINS AND ITS USE 2021
  • Huang, Changjiang
  • Sun, Youxiang
  • Xiong, Jiukai
  • Kong, Nana
  • Yan, Xinxin
RU2795148C2
NEW SYNERGETIC EFFECTS 2009
  • Lutts Robert Dzh.
  • Uajtmehn Kehtlin R.
RU2471499C2
ANTIBODIES AGAINST TENB2 CONSTRUCTED WITH CYSTEINE, AND CONJUGATES, ANTIBODY-DRUG 2008
  • Mao Vehjguan
  • Dzhunutula Dzhagatkh Reddi
  • Polakis Pol
RU2505544C2
ANTIBODIES TO HUMAN INTERLEUKIN-2 AND THEIR APPLICATION 2018
  • Surh, Charles D.
  • Lee, Jun-Young
RU2745451C1
HUMANISED ANTIBODIES AGAINST CD79b AND IMMUNOCONJUGATES AND METHODS OF APPLICATION 2008
  • Chehn', Ivonne
  • Dennis, Mark
  • Ehlkins, Kristi
  • Dzhunutula, Dzhagat Reddi
  • Polson, Ehndrju
  • Chzhehn, Bin
RU2557319C2

RU 2 349 343 C2

Authors

Griffits Gari L.

Dates

2009-03-20Published

2004-01-20Filed